Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
nl Nederlands
en Englishar العربيةbg Българскиzh-CN 简体中文zh-TW 繁體中文hr Hrvatskics Čeština‎da Dansknl Nederlandsfi Suomifr Françaisde Deutschel Ελληνικάhi हिन्दीit Italianoja 日本語ko 한국어no Norsk bokmålpl Polskipt Portuguêsro Românăru Русскийes Españolsv Svenskaca Catalàtl Filipinoiw עִבְרִיתid Bahasa Indonesialv Latviešu valodalt Lietuvių kalbasr Српски језикsk Slovenčinasl Slovenščinauk Українськаvi Tiếng Việtsq Shqipet Eestigl Galegohu Magyarmt Malteseth ไทยtr Türkçefa فارسیaf Afrikaansms Bahasa Melayusw Kiswahiliga Gaeilgecy Cymraegbe Беларуская моваis Íslenskamk Македонски јазикyi יידישhy Հայերենaz Azərbaycan dilieu Euskaraka ქართულიht Kreyol ayisyenur اردوbn বাংলাbs Bosanskiceb Cebuanoeo Esperantogu ગુજરાતીha Harshen Hausahmn Hmongig Igbojw Basa Jawakn ಕನ್ನಡkm ភាសាខ្មែរlo ພາສາລາວla Latinmi Te Reo Māorimr मराठीmn Монголne नेपालीpa ਪੰਜਾਬੀso Afsoomaalita தமிழ்te తెలుగుyo Yorùbázu Zulu
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more

Filter by type

Refine your search

Selected filters

  • subject

    • Erythema nodosum leprosum - enl (Type 2 reaction)

Advanced filters

Filter on Type
Filter on NTD
Filter by Author / Contributor
Erythema nodosum leprosum - enl (Type 2 reaction)486
Filter by Journal
Filter by target audience
Filter by Year of Publication
Filter by Language
Filter on Regional Focus
Filter by Research Group

Selected filters

  • subject

    • Erythema nodosum leprosum - enl (Type 2 reaction)

Advanced filters

Filter on Type
Filter on NTD
Filter by Author / Contributor
Erythema nodosum leprosum - enl (Type 2 reaction)486
Filter by Journal
Filter by target audience
Filter by Year of Publication
Filter by Language
Filter on Regional Focus
Filter by Research Group
486 results
  1. Publications

    Clinical Pearls: Leprosy Reactions.

    Jane Wu, Andrea Boggild. Journal of cutaneous medicine and surgery. 2016;
  2. Publications

    Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.

    Sundeep Chowdhry, Akhilesh Shukla, Paschal D'Souza, et al. International journal of mycobacteriology. 2016; 5 (2) : 223-5.
    Download PDF
  3. Publications

    A retrospective analysis of histopathology of 64 cases of lepra reactions.

    Vijay Adhe, Atul Dongre, Uday Khopkar. Indian journal of dermatology. 2012; 57 (2) : 114-7.
    Download PDF
  4. Publications

    The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.

    AB Fonseca, Marise Simon, Rodrigo Anselmo Cazzaniga, et al. Infectious diseases of poverty. 2017; 6 (1) : 5.
    Download PDF
  5. Publications

    A prospective randomised, double-blind, placebo controlled trial on the effect of extended clofazimine on Erythema Nodosum Leprosum (ENL) in multibacillary (MB) leprosy

    Armi Maghanoy, Marivic Balagon, Paul Saunderson, et al. Leprosy review. 2017; 88 (2) : 208–216.
    Download PDF
  6. Publications

    Therapeutic Dilemma of Refractory Erythema Nodosum Leprosum.

    Jianyu Zhu, Degang Yang, Chao Shi, et al. The American journal of tropical medicine and hygiene. 2017; 96 (6) : 1362-1364.
  7. Publications

    T-cell regulation in Erythema Nodosum Leprosum.

    Edessa Negera, Steven Walker, Kidist Bobosha Armauer Hansen Research Institute, Ethiopia, et al. PLoS neglected tropical diseases. 2017; 11 (10) : e0006001.
    Download PDF
  8. Publications

    Electrophysiological Study of Nerves in Type-II Reaction in Leprosy.

    Santosh Kumar Singh, Sunil Gupta, Mukhija, et al. Indian journal of dermatology. 2017; 62 (6) : 644-648.
    Download PDF
  9. Publications

    The impact of Erythema nodosum leprosum on health related quality of life in Rio de Janeiro

    Anna Sales, Ximena Illarramendi, Stephen L Walker Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK, et al. Leprosy review. 2017; 88 (4) : 499–509.
    Download PDF
  10. Publications

    Familial clustering of severe atypical variants of erythema nodosum leprosum in immunocompetent siblings

    Sarita Sanke, Ram Chander, Abhinav Kumar. Leprosy review. 2017; 88 (4) : 568–573.
    Download PDF
  11. Publications

    Complement C1q expression in Erythema nodosum leprosum.

    Edessa Negera, Stephen L Walker Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK, Tsehainesh Lemma, et al. PLoS neglected tropical diseases. 2018; 12 (3) : e0006321.
    Download PDF
  12. Publications

    Leprosy in Pregnancy: A Case Series in 4 Dermatology Clinics in Malaysia

    Ken Chen Loh, Min Moon Tang, Wooi Chiang Tan, et al. Malaysian journal of dermatology. 2018;
    Download PDF
  13. Publications

    Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.

    Felipe Tavares Rodrigues, Marcos Roberto Pereira Cardozo, Jose Augusto da Costa Nery. The American journal of tropical medicine and hygiene. 2018; 99 (4) : 813-814.
    Download PDF
  14. Publications

    Leprosy Reactions

    Leyla Bilik, Betul Demir, Demet Cicek. Hansen's Disease. IntechOpen 2018;
    Download PDF
  15. Publications

    Bullous Erythema Nodosum Leprosum: A rare entity

    AD Gulanikar, Sharma, Khare. Indian journal of leprosy. 2018;
    Download PDF
  16. Publications

    Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.

    Pugazhenthan Thangaraju, Sajitha Venkatesan, Elavarasan Sivashanmugam, et al. Indian journal of pharmacology. 2019; 51 (1) : 72-74.
    Download PDF
  17. Publications

    Report of informal consultation on treatment of reactions and prevention of disabilities, 11-13 December 2018, Chennai, India.

    World Health Organization, Regional Office for South-East Asia. . World Health Organization 2019;
    Download PDF
  18. Publications

    Resistance as a cause for chronic steroid dependent ENL - a novel paradigm with potential implications in management

    Arora, Sardana, Agarwal, et al. Leprosy review. 2019; 90 (2) : 201– 205.
    Download PDF
  19. Publications

    Expression of FoxP3 in different forms of leprosy and reactions

    Chalita Patricia Lima, Elisa Costa, Lucas Sampaio. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2019;
    Download PDF
  20. Publications

    Erythema nodosum leprosum in Singapore.

    Giam, Ong, Tan. Annals of the Academy of Medicine, Singapore. 1987; 16 (4) : 658-62.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 25

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

You can select items on multiple pages (max. 100).
Select...

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD

Modal.